SS Innovations International, Inc. Overview
Pro stress-test →SS Innovations International is a developer of surgical robotic technologies, with its core product being the proprietary SSi Mantra surgical robotic system and a comprehensive suite of SSi Mudra surgical instruments supporting a variety of procedures including robotic cardiac surgery. The company is dedicated to making robotic surgery affordable and accessible to a global population.
Strategic Profile
Pro stress-test →The company uplisted to Nasdaq Capital Market in April 2025 and continues trading under the ticker SSII. SS Innovations is pursuing global expansion beyond India into Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka and Ukraine, while pursuing EU CE Mark and U.S. FDA approval for its SSi Mantra surgical robotic system, anticipated in late 2025 and early 2026 respectively. The company expects to report full year 2025 revenue of approximately $43.0 million, up 108% from $20.6 million in 2024.
Competitive Landscape
Pro stress-test →Competitors in the surgical robotics space include Vicarious Surgical Inc. and Allurion Technologies Inc. SS Innovations differentiates itself through its focus on affordability and accessibility, particularly in emerging markets beyond the established players like da Vinci Systems. The company's India-based operations and rapid deployment of systems internationally provide cost advantages, though it faces significant competitive pressure from well-capitalized incumbents seeking to expand in lower-cost markets.
Industry Context
SS Innovations International, Inc. operates in Surgical robotic systems.
Key facts
Founded: 2019 · Headquarters: Gurugram, India · Employees: 378 · Revenue: $43.0M (2025E) · Market cap: $1.2B